Latest Articles on Mesothelioma and Asbestos
What Is Ramucirumab and How Does It Help for Mesothelioma?
Doctors are regularly combining different cancer therapies, trying to find a magic bullet to cure cancer or at least extend survival by a few precious weeks or months. One drug in the experimental...
View ArticleThree Effective Stress Management Techniques for Mesothelioma Patients
Any cancer diagnosis can cause stress. Cancer patients have to make many important decisions that can affect their quality of life. For example, mesothelioma… The post Three Effective Stress Management...
View Article
Second-Line Treatment with Ramucirumab Improves Mesothelioma Survival
New evidence suggests that second-line treatment with ramucirumab after first-line chemotherapy may lead to longer survival in people with pleural mesothelioma. Researchers in Italy recently published...
View Article
Second-Line Treatment with Ramucirumab Improves Mesothelioma Survival
New evidence suggests that second-line treatment with ramucirumab after first-line chemotherapy may lead to longer survival in people with pleural mesothelioma. Researchers in Italy recently published...
View ArticleSignificance of p53 immunostaining in mesothelial proliferations and...
Modern Pathology 2021 September 8 [Link] Julia R Naso, Basile Tessier-Cloutier, Janine Senz, David G Huntsman, Andrew Churg Abstract p53 immunohistochemistry has long been proposed for the separation...
View ArticleSignificance of p53 immunostaining in mesothelial proliferations and...
Modern Pathology 2021 September 8 [Link] Julia R Naso, Basile Tessier-Cloutier, Janine Senz, David G Huntsman, Andrew Churg Abstract p53 immunohistochemistry has long been proposed for the separation...
View ArticleSignificance of p53 immunostaining in mesothelial proliferations and...
Modern Pathology 2021 September 8 [Link] Julia R Naso, Basile Tessier-Cloutier, Janine Senz, David G Huntsman, Andrew Churg Abstract p53 immunohistochemistry has long been proposed for the separation...
View ArticleParticipants needed for study exploring the experience of living with pleural...
One of the Mesothelioma UK and Lung Cancer Nursing UK 2020 research grants awarded to Dr Matt Johnson, Macmillan Lead Cancer Nurse, based at Royal Brompton and Harefield Hospitals, has been...
View Article
Yervoy and Opdivo for Mesothelioma: Three Year Results Still Look Good
Three years after the last patients enrolled in the clinical trial of Yervoy and Opdivo for mesothelioma, survival results still look promising for this immunotherapy treatment. Researchers presented...
View Article
Yervoy and Opdivo for Mesothelioma: Three Year Results Still Look Good
Three years after the last patients enrolled in the clinical trial of Yervoy and Opdivo for mesothelioma, survival results still look promising for this immunotherapy treatment. Researchers presented...
View Article
